GlobeNewswire: Intricon Corporation Contains the last 10 of 47 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T04:40:32ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/05/24/2449754/0/en/Intricon-Announces-Completion-of-Acquisition-by-an-Affiliate-of-Altaris-Capital-Partners.html?f=22&fvtc=4&fvtv=53876Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners2022-05-24T20:05:00Z<![CDATA[Investment by Altaris Supports Intricon’s Ability to Deliver Innovative Solutions and Service to its Customers Investment by Altaris Supports Intricon’s Ability to Deliver Innovative Solutions and Service to its Customers]]>https://www.globenewswire.com/news-release/2022/02/28/2393218/0/en/Intricon-Reports-Fourth-Quarter-and-Full-Year-2021-Results.html?f=22&fvtc=4&fvtv=53876Intricon Reports Fourth Quarter and Full Year 2021 Results2022-02-28T13:40:00Z<![CDATA[ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021.]]>https://www.globenewswire.com/news-release/2022/02/28/2393212/0/en/Intricon-Enters-into-Agreement-to-be-Acquired-by-an-Affiliate-of-Altaris-Capital-Partners-for-241-Million.html?f=22&fvtc=4&fvtv=53876Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million2022-02-28T13:35:00Z<![CDATA[Intricon Shareholders to Receive $24.25 Per Share in Cash Intricon Shareholders to Receive $24.25 Per Share in Cash]]>https://www.globenewswire.com/news-release/2021/11/09/2330881/0/en/Intricon-to-Present-at-the-Virtual-2021-Stifel-Healthcare-Conference.html?f=22&fvtc=4&fvtv=53876Intricon to Present at the Virtual 2021 Stifel Healthcare Conference2021-11-09T21:05:00Z<![CDATA[ARDEN HILLS, Minn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, Intricon’s President and Chief Executive Officer, will present at the upcoming Virtual 2021 Stifel Healthcare Conference.]]>https://www.globenewswire.com/news-release/2021/11/08/2329723/0/en/Intricon-Reports-Third-Quarter-2021-Results.html?f=22&fvtc=4&fvtv=53876Intricon Reports Third Quarter 2021 Results2021-11-08T21:05:00Z<![CDATA[ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021.]]>https://www.globenewswire.com/news-release/2021/10/29/2323927/0/en/Intricon-Announces-CFO-Departure-and-Preliminary-Third-Quarter-2021-Revenue.html?f=22&fvtc=4&fvtv=53876Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue2021-10-29T20:05:00Z<![CDATA[ARDEN HILLS, Minn., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has stepped down from her position as Chief Financial Officer, effective October 29, 2021. Annalee Lutgen, current Treasurer and Director of Finance, will serve as interim Chief Financial Officer effective upon Ms. Scipta’s resignation as the company conducts its search for a permanent replacement.]]>https://www.globenewswire.com/news-release/2021/10/25/2320165/0/en/Intricon-to-Announce-2021-Third-Quarter-Results-on-Monday-November-8-2021.html?f=22&fvtc=4&fvtv=53876Intricon to Announce 2021 Third Quarter Results on Monday, November 8, 20212021-10-25T20:05:00Z<![CDATA[ARDEN HILLS, Minn., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 third quarter results on Monday, November 8, 2021, after market close.]]>https://www.globenewswire.com/news-release/2021/10/20/2317783/0/en/Intricon-Applauds-FDA-s-Proposal-to-Improve-Access-to-Hearing-Aid-Technology-for-Millions-of-Americans-Paving-the-Way-for-Over-the-Counter-Hearing-Aids.html?f=22&fvtc=4&fvtv=53876Intricon Applauds FDA's Proposal to Improve Access to Hearing Aid Technology for Millions of Americans, Paving the Way for Over-the-Counter Hearing Aids2021-10-20T20:05:00Z<![CDATA[OTC Hearing Aid Act designed to offer greater public access to hearing aids at a lower costIntricon well positioned to provide the ecosystem necessary to deliver high customer satisfaction]]>https://www.globenewswire.com/news-release/2021/09/30/2306626/0/en/Intricon-Self-Fitting-Technology-for-Over-The-Counter-Hearing-Aids-Clears-Clinical-Trial-Milestone.html?f=22&fvtc=4&fvtv=53876Intricon Self-Fitting Technology for Over-The-Counter Hearing Aids Clears Clinical Trial Milestone2021-09-30T20:05:00Z<![CDATA[New software will strengthen Intricon’s ability to meet consumer demand for hearing aids sold at retail and online New software will strengthen Intricon’s ability to meet consumer demand for hearing aids sold at retail and online]]>https://www.globenewswire.com/news-release/2021/08/09/2277403/0/en/Intricon-Reports-Second-Quarter-2021-Results.html?f=22&fvtc=4&fvtv=53876Intricon Reports Second Quarter 2021 Results2021-08-09T20:05:00Z<![CDATA[ARDEN HILLS, Minn., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its second quarter ended June 30, 2021.]]>